Self-organizing-map-based molecular signature representing the development of hepatocellular carcinoma

FEBS Letters

Volumn 579, Issue 5, 2005, Pages 1089-1100

  Iizuka, Norio ^a   Oka, Masaaki ^a   Yamada Okabe, Hisafumi ^b   Mori, Naohide ^a   Tamesa, Takao ^a   Okada, Toshimasa ^a   Takemoto, Norikazu ^a   Sakamoto, Kazuhiko ^a   Hamada, Kenji ^b   Ishitsuka, Hideo ^b,d   Miyamoto, Takanobu ^c   Uchimura, Shunji ^c   Hamamoto, Yoshihiko ^c  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^c YAMAGUCHI UNIVERSITY   (Japan)

^d Roche Diagnostics KK   (Japan)

Author keywords

Dedifferentiation; DNA microarray; HCC; HCV; Hepatocellular carcinoma

Indexed keywords

PROTEIN P53;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; ARTIFICIAL NEURAL NETWORK; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; FISHER EXACT TEST; GENE CLUSTER; GENE EXPRESSION; GENE MAPPING; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROLOGY; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; UNINDEXED SEQUENCE;

EID: 13844286027     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2004.10.113     Document Type: Article

References (42)

1. H.B. El-Serag, and A.C. Mason Rising incidence of hepatocellular carcinoma in the United States N. Engl. J. Med. 340 1999 745 750
2. D.F. Schafer, and M.F. Sorrell Hepatocellular carcinoma Lancet 353 1999 1253 1257
3. J.M. Llovet, A. Burroughs, and J. Bruix Hepatocellular carcinoma Lancet 362 2003 1907 1917
4. M.S. De Mitri, E. Pisi, K. Poussin, P. Paterlini, C. Bréchot, P. Baccarini, A. D'Errico, W. Grigiani, A. Alberti, P. Pontisso, N. Simon, and M. Beaugrand HCV-associated liver cancer without cirrhosis Lancet 345 1995 413 415
5. S.S. Thorgeirsson, and J.W. Grisham Molecular pathogenesis of human hepatocellular carcinoma Nat. Genet. 31 2002 339 346
6. C.M. Kim, K. Koike, I. Saito, T. Miyamura, and G. Jay HBx gene of hepatitis B virus induces liver cancer in transgenic mice Nature 351 1991 317 320
7. K. Moriya, H. Fujie, Y. Shintani, H. Yotsuyanagi, T. Tsutsumi, K. Ishibashi, Y. Matsuura, S. Kimura, T. Miyamura, and K. Koike The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice Nat. Med. 4 1998 1065 1067
8. S. Satoh, Y. Daigo, Y. Furukawa, T. Kato, N. Miwa, T. Nishiwaki, T. Kawasoe, H. Ishiguro, M. Fujita, T. Tokino, Y. Sasaki, S. Imaoka, M. Murata, T. Shimano, Y. Yamaoka, and Y. Nakamura AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1 Nat. Genet. 24 2000 245 250
9. T. Oda, H. Tsuda, A. Scarpa, M. Sakamoto, and S. Hirohashi p53 gene mutation spectrum in hepatocellular carcinoma Cancer Res. 52 1992 6358 6364
10. H. Tsuda, W.D. Zhang, Y. Shimosato, J. Yokota, M. Terada, T. Sugimura, T. Miyamura, and S. Hirohashi Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma Proc. Natl. Acad. Sci. USA 87 1990 6791 6794
11. O. Nakashima, S. Sugihara, M. Kage, and M. Kojiro Pathomorphologic characteristics of small hepatocellular carcinoma: a special reference to small hepatocellular carcinoma with indistinct margins Hepatology 22 1995 101 105
12. S. Sugihara, O. Nakashima, M. Kojiro, Y. Majima, M. Tanaka, and K. Tanikawa The morphologic transition in hepatocellular carcinoma. A comparison of the individual histologic features disclosed by ultrasound-guided fine-needle biopsy with those of autopsy Cancer 70 1992 1488 1492
13. M. Kojiro Pathological evolution of early hepatocellular carcinoma Oncology 62 2002 43 47
14. N. Iizuka, M. Oka, H. Yamada-Okabe, N. Mori, T. Tamesa, T. Okada, N. Takemoto, A. Tangoku, K. Hamada, H. Nakayama, T. Miyamoto, S. Uchimura, and Y. Hamamoto Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data based on a supervised learning method Cancer Res. 62 2002 3939 3944
15. N. Iizuka, M. Oka, H. Yamada-Okabe, N. Mori, T. Tamesa, T. Okada, N. Takemoto, K. Hashimoto, A. Tangoku, K. Hamada, H. Nakayama, T. Miyamoto, S. Uchimura, and Y. Hamamoto Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis Oncogene 22 2003 3007 3014
16. N. Iizuka, M. Oka, H. Yamada-Okabe, M. Nishida, Y. Maeda, N. Mori, T. Takao, T. Tamesa, A. Tangoku, H. Tabuchi, K. Hamada, H. Nakayama, H. Ishitsuka, T. Miyamoto, A. Hirabayashi, S. Uchimura, and Y. Hamamoto Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection Lancet 361 2003 923 929
17. T. Okada, N. Iizuka, H. Yamada-Okabe, N. Mori, T. Tamesa, N. Takemoto, A. Tangoku, K. Hamada, H. Nakayama, T. Miyamoto, S. Uchimura, Y. Hamamoto, and M. Oka Gene expression profile linked to p53 status in hepatitis C virus-related hepatocellular carcinoma FEBS Lett. 555 2003 583 590
18. P. Tamayo, D. Slonim, J. Mesirov, Q. Zhu, S. Kitareewan, E. Dmitrovsky, E.S. Lander, and T.R. Golub Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation Proc. Natl. Acad. Sci. USA 96 1999 2907 2912
19. P. Toronen, M. Kolehmainen, G. Wong, and E. Castren Analysis of gene expression data using self-organizing maps FEBS Lett. 451 1999 142 146
20. L.H. Sobin, and C. Wittekind TNM classification of Malignant Tumours sixth ed. 2002 UICC, Wiley-Liss 81-83
21. N. Iizuka, M. Oka, K. Yamamoto, A. Tangoku, K. Miyamoto, T. Miyamoto, S. Uchimura, Y. Hamamoto, and K. Okita Identification of common or distinct genes related to antitumor activities of a medicinal herb and its major component by oligonucleotide microarray Int. J. Cancer 107 2003 666 672
22. V.G. Tusher, R. Tibshirani, and G. Chu Significance analysis of microarrays applied to the ionizing radiation response Proc. Natl. Acad. Sci. USA 98 2001 5116 5121
23. M. Schena, D. Shalon, R.W. Davis, and P.O. Brown Quantitative monitoring of gene expression patterns with a complementary DNA microarray Science 270 1995 467 470
24. J. DeRisi, L. Penland, P.O. Brown, M.L. Bittner, P.S. Meltzer, M. Ray, Y. Chen, Y.A. Su, and J.M. Trent Use of a cDNA microarray to analyse gene expression patterns in human cancer Nat. Genet. 14 1996 457 460
25. J.W. Kim, and X.W. Wang Gene expression profiling of preneoplastic liver disease and liver cancer: a new era for improved early detection and treatment of these deadly diseases? Carcinogenesis 24 2003 363 369
26. Y. Shirota, S. Kaneko, M. Honda, H.F. Kawai, and K. Kobayashi Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays Hepatology 33 2001 832 840
27. H. Okabe, S. Satoh, T. Kato, O. Kitahara, R. Yanagawa, Y. Yamaoka, T. Tsunoda, Y. Furukawa, and Y. Nakamura Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression Cancer Res. 61 2001 2129 2137
28. Y. Midorikawa, S. Tsutsumi, H. Taniguchi, M. Ishii, Y. Kobune, T. Kodama, M. Makuuchi, and H. Aburatani Identification of genes associated with dedifferentiation of hepatocellular carcinoma with expression profiling analysis Jpn. J. Cancer Res. 93 2002 636 643
29. M. Chuma, M. Sakamoto, K. Yamazaki, T. Ohta, M. Ohki, M. Asaka, and S. Hirohashi Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma Hepatology 37 2003 198 207
30. M.W. Smith, Z.N. Yue, G.K. Geiss, N.Y. Sadovnikova, V.S. Carter, L. Boix, C.A. Lazaro, G.B. Rosenberg, R.E. Bumgarner, N. Fausto, J. Bruix, and M.G. Katze Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma Cancer Res. 63 2003 664 859
31. X. Chen, S.T. Cheung, S. So, S.T. Fan, C. Barry, J. Higgins, K.M. Lai, J. Ji, S. Dudoit, I.O. Ng, M. Van De Rijn, D. Botstein, and P.O. Brown Gene expression patterns in human liver cancers Mol. Biol. Cell 13 2002 1929 1939
32. O. Delpuech, J.B. Trabut, F. Carnot, J. Feuillard, C. Brechot, and D. Kremsdorf dentification, using cDNA macroarray analysis, of distinct gene expression profiles associated with pathological and virological features of hepatocellular carcinoma Oncogene 21 2002 2926 2937
33. T. Poynard, P. Bedossa, and P. Opolon atural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups Lancet 349 1997 825 832
34. E.C. Kohn, and L.A. Liotta Molecular insights into cancer invasion: strategies for prevention and intervention Cancer Res. 55 1995 1856 1862
35. B. Vogelstein, E.R. Fearon, S.R. Hamilton, S.E. Kern, A.C. Preisinger, M. Leppert, Y. Nakamura, R. White, A.M. Smits, and J.L. Bos Genetic alterations during colorectal-tumor development N. Engl. J. Med. 319 1988 525 532
36. M.W. Smith, Z.N. Yue, M.J. Korth, H.A. Do, L. Boix, N. Fausto, J. Bruix, R.L. Carithers Jr., and M.G. Katze Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers Hepatology 38 2003 1458 1467
37. W.C. Hung, and L.Y. Chuang Sodium butyrate enhances STAT 1 expression in PLC/PRF/5 hepatoma cells and augments their responsiveness to interferon-alpha Br. J. Cancer 80 1999 705 710
38. G.K. Geiss, V.S. Carter, Y. He, B.K. Kwieciszewski, T. Holzman, M.J. Korth, C.A. Lazaro, N. Fausto, R.E. Bumgarner, and M.G. Katze Gene expression profiling of the cellular transcriptional network regulated by alpha/beta interferon and its partial attenuation by the hepatitis C virus nonstructural 5A protein J. Virol. 77 2003 6367 6375
39. D.W. Ohannesian, D. Lotan, P. Thomas, J.M. Jessup, M. Fukuda, H.J. Gabius, and R. Lotan Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells Cancer Res. 55 1995 2191 2199
40. G. Giannelli, E. Fransvea, F. Marinosci, C. Bergamini, S. Colucci, O. Schiraldi, and S. Antonaci Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin Am. J. Pathol. 16 2002 183 193
41. A. Matsumoto, M. Ono, Y. Fujimoto, R.L. Gallo, M. Bernfield, and Y. Kohgo Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential Int. J. Cancer 74 1997 482 491
42. J.M. Llovet, and E. Wurmbach Gene expression profiles in hepatocellular carcinoma: not yet there J. Hepatol. 41 2004 336 339